Ingenious e-Brain Solutions forecasts that the cancer vaccines market will witness a significant increase within the coming five years. Major factors driving the cancer vaccine market growth include the increasing number of cancer cases, rising investments and funding by government organizations for developing cancer vaccines, and technological developments in cancer vaccines platforms.
Cancer vaccines development has been intensively pursued over the past half decade with moderate success. However, recent advancements in the fields of molecular biology, genetics, biochemistry, and immunology have renewed interest and allowed the development of promising cancer vaccine candidates.
Various on-going clinical trials testing of advanced vaccines candidates with the desirable target characteristics are capable of inducing strong tumour-specific non-toxic responses and can provide the maximum clinical benefit to patients. Furthermore, growing knowledge of the mechanisms by which tumours evade the immune response has led to new approaches for personalized vaccine development.
In this report, different vaccine platforms such as nucleic acids, proteins, cell based, oncolytic virus based platforms, and antigenic technologies are provided. Recent developments, comparative analysis of various vaccine platforms, established players, and future prospects of cancer vaccines are highlighted in addition to details related to collaboration/ acquisition opportunities, patenting activity in the field of cancer vaccine is included along with some other sections which are listed in the table of content of the report.
The global cancer vaccines market is segmented on the basis of technology, type, indication, end user, and region. By technology, the market is categorized into dendritic cells (DC) cancer vaccines, recombinant cancer vaccines, antigen/adjuvant cancer vaccines, and viral vector & DNA cancer vaccines. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America is expected to grow due to the high prevalence of cancer and developed healthcare infrastructure in the region.
More details @ https://www.iebrain.com/reports/cancer-vaccine-platforms/
